Comparative Value of Traditional versus Novel Immune-Inflammatory Indices in Assessing Disease Activity of Sjögren’s Disease: A Multicenter Cohort Study

Ya-Qi Zhao Xunjun Dong Ping-Ting Yang Jiu-Liang Zhao W. Bai Xin-Ping Tian Wen Zhang Meng-Tao Li Xiao-Feng Zeng X. Leng

Jul 2026 · Clinical Rheumatology · Vol 45, pp. 5625 - 5639 · 0 citations · 34 references

Medicine

TL;DR

The XGBoost machine learning model effectively handles non-linear variables and highlights the core diagnostic importance of patient-reported outcomes (ESSPRI) and traditional clinical features, providing a favorable evaluation tool.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Oct 2026

Composite Complete-Blood-Count-Derived Inflammatory Indices for Discriminating Established Major Organ Involvement in Behçet’s Disease: A Cross-Sectional Nomogram Model

Introduction: Differentiating major organ involvement (MOI) from isolated mucocutaneous manifestations in Behçet’s disease (BD) remains a substantial clinical challenge, particularly in stable outpatients outside acute flares. This study aimed to evaluate the cross-sectional discriminatory utility of complete blood cou...

Süleyman Gül, M. Özdemir, H. Ecesoy · Journal of Clinical Medicine · 0 citations

Open access Sep 2026

Aggregate Index of Systemic Inflammation in Behçet’s Disease: Association with Disease Activity

Objective: The aggregate index of systemic inflammation (AISI) is a recently introduced composite inflammatory marker derived from neutrophil, monocyte, lymphocyte, and platelet counts. This study aimed to evaluate AISI values in patients with Behçet’s disease (BD), compare them with healthy controls, and investigate t...

Zeynep Kaya, S. Ösken · Rheumatology Quarterly · 0 citations

Open access Sep 2026

Evaluation of Systemic Immune-Inflammation Index and Systemic Inflammation Response Index in Children with Celiac Disease

Background: Celiac disease is an enteropathy characterized by intestinal inflammation and systemic immune activation. In recent years, there has been a rising focus on systemic inflammation markers obtained from complete blood count parameters, including the Systemic Immune-Inflammation Index (SII) and the Systemic Inf...

Neslihan Gürcan Kaya, Semih Sandal · Dicle Tıp Dergisi · 0 citations

Open access Oct 2026

FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies

Background: Identifying novel, reliable blood-based biomarkers is essential to better assess disease activity in idiopathic inflammatory myopathies (IIMs). We aimed to determine serum fatty acid binding protein 3 (FABP3) levels in IIM patients and evaluated their correlations with disease activity, muscle strength, and...

Dorottya Szinay, Katalin Szabó, T. Béldi et al. · Biomolecules · 0 citations

Open access Oct 2026

Hematological Biomarkers and Disease Activity in Rheumatoid Arthritis: A Retrospective Cross-Sectional Study in Peruvian Patients

Rheumatoid arthritis (RA) is a chronic inflammatory disease in which accurate assessment of disease activity is essential for optimizing treatment strategies. Hematological indices derived from routine blood tests, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic im...

Yelitza Velarde-Mejía, Guillermo Velarde Paredes, Ventura Mejia Mena et al. · Clinical Medicine Insights:... · 0 citations

Open access Sep 2026

Hematological inflammatory markers as predictors of atherosclerotic progression in patients with psoriasis: A retrospective case–control study from the SH-YIMED database

Neutrophil-to-lymphocyte ratio and systemic immune-inflammation index improved cardiovascular risk prediction for patients with psoriasis with atherosclerosis, enabling effective risk stratification.

Miao Zhang, Mun-Gwan Hong, Rui-Qing Cao et al. · JID Innovations · 0 citations